|
| April
7, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
- Amgen:
Positive Topline Phase 3 Results for
Subcutaneous Tepezza in Adults Living With
Moderate-to-Severe Active Thyroid Eye
Disease More
More
More*
- Biocom:
Section 232 Pharmaceutical Tariffs
- Statement More
- Defense
Diagnostics: Will Exhibit DEFENT ONE Fentanyl
Detection Device at the 2026 Rx and Illicit
Drug Summit More
- Doheny
Eye Institute: Welcomes Alicia Cleaver as
Chief Development Officer With Support From
Envision Consulting More
- egnite:
Receives U.S. Patent for NLP-Based Algorithm
That Classifies Mitral Regurgitation Mechanism
From Echocardiographic Reports More
- GATC
Health and UC Irvine: Landmark PNAS
Publication Validating AI-Platform for
Opioid Use Disorder Treatment More
More
- IMF:
Dr. Joseph Mikhael Steps Into New Role as
Medical Advisor for the International Myeloma
Foundation More
- ImmunityBio:
Addresses FDA Correspondence and Reaffirms
Commitment to Advertising Compliance More
More
- Johnson
& Johnson: Advances Pulsed Field Ablation
Portfolio With the Launch of VARIPULSE Pro in
Europe More
- Maximus:
Ranked #7 on the Financial Times' List of The
Americas' Fastest Growing Companies 2026 More
- The
Lundquist Institute: Researchers Discover New
Immune Pathway That Strengthens Oral Mucosal
Defenses Against Fungal Infection More
|
|
- AEON
Biopharma: Inducement Grants Under NYSE
American LLC Company Guide Section 711 More
- AEON
Biopharma: Receives Additional Notice Related
to NYSE American Continued Listing Standards More
- March
M&A Surge Triggers High Expectations for
2026 More
- OSI
Systems: Receives $40 Million Award for
Medical Device Sub-Assemblies More
- Puma
Biotechnology: Inducement Awards Under Nasdaq
Listing Rule 5635(c)(4) More
- USC:
NIH Investment Totaling 30.7M Will Expand
USC-Led AI Effort to Decode Alzheimer's
Disease More
|
|
- AI in Silico Multi-Omics Technique Cuts
Therapeutic Development Costs More
- Biotech Hangout: Episode 178 Podcast
- Biotech Firm Gets a New Leader More*
- BioPharmGuy News: Moon Rocket, Fake Masters,
Organ Sacks, Fly Brain, Dead Tortoise More
- Electroacupuncture Shows Promise in Breast
Cancer Survivors, UC Irvine-Led Study Finds More
- How AI and Advanced Computing Are
Accelerating Alzheimer's Research More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- UCLA Researchers Develop Low-Cost
Blood Test to Detect Multiple Cancers and
Other Diseases from a Single Sample More
More
|
|
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- Empowering Students through STEM: A
Conversation with Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- ICYMI: The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping
- Lilly’s Chief Technology Officer Retires
After 35 Years; Astellas Strategy Exec Resigns
More*
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|